MARKET PULSE-Zalicus, CollabRx, ViroPharma, Cirrus Logic, Gogo

Mon Nov 11, 2013 10:23am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter; for the Morning News Call newsletter,

U.S. stocks were little changed on Monday as investors took a breather after the Dow and the S&P 500 indexes rose five weeks in a row. The Dow Jones industrial average was down 0.01 percent, the Standard & Poor's 500 Index 0.04 percent and the Nasdaq Composite Index 0.15 percent.

** ZALICUS INC, $1.22, down 74 pct (9:39 a.m. ET)

The company said it would stop developing its most advanced product, an experimental pain drug, after it failed to show a benefit over a placebo in two mid-stage trials.

** COLLABRX INC, $6.50, up 54 pct (9:40 a.m. ET)

The data analytics firm signed a multi-year agreement with Quest Diagnostics Inc to use the company's clinical test reports in Quest's cancer sequencing tests. Financial details of the deal were not disclosed.   Continued...